Form of presentation | Articles in international journals and collections |
Year of publication | 2022 |
Язык | английский |
|
Abramov Sergey Nikolaevich, author
Abramova Zinaida Ivanovna, author
Ganeeva Liliya Akhatovna, author
Skibo Yuliya Valerevna, author
|
|
LEGBA BORIS B. , author
Voodunon Sirill , author
|
Bibliographic description in the original language |
Ganeeva I. A. Role of the catalytic activity of dna-antibodies in the diagnosis and monitoring of the progression of different clinical forms of cardiovascular disease/I. A. Ganeeva, C. A. Vodounon, S. N. Abramov, B. B. Legba, H. R.I. Mamadou, Y. V. Skibo , Z. I. Abramova// The Journal of Biochemistry.-2022 (ID is JB-22-08-0283 na recenzirovanii, IF-3.241, Q2) |
Annotation |
Coronary heart disease is a major health problem worldwide. One of the current challenges related to its prevention is that of early diagnosis. This study focuses on the search for predictive immunological biomarkers for the diagnosis and control of the evolution of different clinical forms of cardiovascular diseases. Anti-DNA antibodies were searched in the blood serum of 57 patients with cardiovascular disease of various forms and 27 relatively healthy donors who gave their consent. The determination of the level of anti-DNA antibodies was carried out by enzyme immunoassay. The catalytic activity of the anti-DNA antibody was estimated by the agarose gel electrophoresis method. The results showed a significant increase in the levels of anti-nDNA Ac and anti-dDNA Ac between groups of patients with cardiovascular disease. A high anti-nDNA Ac level was observed in 70.70% of patients with cardiovascular diseases. The anti-DNA antibodies found in the serum of the different groups exhibit catalytic activities and are able to transform the super-coiled DNA into linear and circular DNA. From these data, it appears that anti-DNA autoantibodies play a preponderant role in the pathogenesis of cardiovascular diseases and could be used as a biomarker in the diagnosis of this disease |
Keywords |
anti-DNA antibodies, catalytic activities, cardiovascular diseases, biomarker, diagnosis |
The name of the journal |
The Journal of Biochemistry
|
URL |
https://cloud.mail.ru/attaches/101c9E372C7fb56986238Bd3Bf6Ff095%3BgD9cZSB1tT1tddyW |
Please use this ID to quote from or refer to the card |
https://repository.kpfu.ru/eng/?p_id=272643&p_lang=2 |
Full metadata record |
Field DC |
Value |
Language |
dc.contributor.author |
Abramov Sergey Nikolaevich |
ru_RU |
dc.contributor.author |
Abramova Zinaida Ivanovna |
ru_RU |
dc.contributor.author |
Ganeeva Liliya Akhatovna |
ru_RU |
dc.contributor.author |
Skibo Yuliya Valerevna |
ru_RU |
dc.contributor.author |
LEGBA BORIS B. |
ru_RU |
dc.contributor.author |
Voodunon Sirill |
ru_RU |
dc.date.accessioned |
2022-01-01T00:00:00Z |
ru_RU |
dc.date.available |
2022-01-01T00:00:00Z |
ru_RU |
dc.date.issued |
2022 |
ru_RU |
dc.identifier.citation |
Ganeeva I. A. Role of the catalytic activity of dna-antibodies in the diagnosis and monitoring of the progression of different clinical forms of cardiovascular disease/I. A. Ganeeva, C. A. Vodounon, S. N. Abramov, B. B. Legba, H. R.I. Mamadou, Y. V. Skibo , Z. I. Abramova// The Journal of Biochemistry.-2022 (ID is JB-22-08-0283 на рецензировании, IF-3.241, Q2) |
ru_RU |
dc.identifier.uri |
https://repository.kpfu.ru/eng/?p_id=272643&p_lang=2 |
ru_RU |
dc.description.abstract |
The Journal of Biochemistry |
ru_RU |
dc.description.abstract |
Coronary heart disease is a major health problem worldwide. One of the current challenges related to its prevention is that of early diagnosis. This study focuses on the search for predictive immunological biomarkers for the diagnosis and control of the evolution of different clinical forms of cardiovascular diseases. Anti-DNA antibodies were searched in the blood serum of 57 patients with cardiovascular disease of various forms and 27 relatively healthy donors who gave their consent. The determination of the level of anti-DNA antibodies was carried out by enzyme immunoassay. The catalytic activity of the anti-DNA antibody was estimated by the agarose gel electrophoresis method. The results showed a significant increase in the levels of anti-nDNA Ac and anti-dDNA Ac between groups of patients with cardiovascular disease. A high anti-nDNA Ac level was observed in 70.70% of patients with cardiovascular diseases. The anti-DNA antibodies found in the serum of the different groups exhibit catalytic activities and are able to transform the super-coiled DNA into linear and circular DNA. From these data, it appears that anti-DNA autoantibodies play a preponderant role in the pathogenesis of cardiovascular diseases and could be used as a biomarker in the diagnosis of this disease |
ru_RU |
dc.language.iso |
ru |
ru_RU |
dc.subject |
anti-DNA antibodies |
ru_RU |
dc.subject |
catalytic activities |
ru_RU |
dc.subject |
cardiovascular diseases |
ru_RU |
dc.subject |
biomarker |
ru_RU |
dc.subject |
diagnosis |
ru_RU |
dc.title |
Role of the catalytic activity of dna-antibodies in the diagnosis and monitoring of the progression of different clinical forms of cardiovascular disease |
ru_RU |
dc.type |
Articles in international journals and collections |
ru_RU |
|